
Founding chief executive of Facebook Australia and New Zealand, now CEO and co-founder of Omniscient Neurotechnology, an AI-driven brain-mapping company. Stephen Scheeler's Quicktome platform is FDA-approved, and the company secured a $20 million federal investment in early 2026 toward a $36 million Series D round.
acta is a vetted directory. Only vetted members see talent profiles in full.